Form 4 Filing for Apyx Medical Corp - Insider Transaction

Charles D. Goodwin II, Chief Executive Officer and Director of Apyx Medical Corp (APYX), reported a transaction on June 11, 2026. Goodwin was granted a stock option to purchase 213,948 shares of Common Stock at a price of $4.65 per share. This option will vest ratably over a thirty-six (36) month period, with full vesting on the third anniversary of the grant date. The option has an expiration date of June 11, 2036. This is a derivative transaction under D ownership nature. The filing is a Form 4 document.